tiprankstipranks
Trending News
More News >
Lexington Biosciences Inc (LXGTF)
OTHER OTC:LXGTF
US Market

Lexington Biosciences (LXGTF) Income Statement

Compare
7 Followers

Lexington Biosciences Income Statement

Last quarter (Q3 2024), Lexington Biosciences's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Lexington Biosciences's net income was C$-39.47K. See Lexington Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 157.83KC$ 173.48KC$ 312.63KC$ 459.50KC$ 533.53K
Depreciation and Amortization
C$ 157.83KC$ 173.48KC$ 312.63KC$ 459.50KC$ 0.00
EBITDA
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ -1.15M
Operating Income
C$ -158.00KC$ -173.48KC$ -312.63KC$ -459.50KC$ -533.53K
Other Income/Expenses
C$ -19.55KC$ -2.49KC$ -11.61KC$ -21.12KC$ -736.25K
Pretax Income
C$ -177.00KC$ -175.97KC$ -324.24KC$ -480.62KC$ -1.27M
Net Income
C$ -177.38KC$ -175.00C$ -324.24KC$ -480.00C$ -1.27M
Per Share Metrics
Basic EPS
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ -0.34
Diluted EPS
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ -0.34
Weighted Average Shares Outstanding
17.74M 27.46M 27.46M 12.05M 3.79M
Weighted Average Shares Outstanding (Diluted)
27.46M 27.46M 27.46M 12.05M 3.79M
Currency in CAD

Lexington Biosciences Earnings and Revenue History